- Home
- EPSM vs NTRB Comparison
EPSM vs NTRB Comparison
Compare EPSM & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EPSM | NTRB |
|---|---|---|
| Founded | 2010 | 2016 |
| Country | China | United States |
| Employees | N/A | 3 |
| Industry | | Industrial Specialties |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.6M | 44.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | EPSM | NTRB |
|---|---|---|
| Price | $1.38 | $4.08 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 18.4K | 8.4K |
| Earning Date | 05-24-2026 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $30.17 |
| Revenue Next Year | N/A | $3,394.36 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.04 | $3.42 |
| 52 Week High | $155.00 | $11.68 |
Technical Indicators
Market Signals| Indicator | EPSM | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 45.24 | 53.42 |
| Support Level | $1.31 | $3.51 |
| Resistance Level | $1.69 | $4.50 |
| Average True Range (ATR) | 0.12 | 0.27 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 24.87 | 70.51 |
Price Performance
Historical ComparisonAbout EPSM Epsium Enterprise Limited Ordinary Shares
Epsium Enterprise Ltd is a holding company and conducts business through its subsidiaries. It is engaged in import trading and wholesale selling of beverages in Macau. The company imports and sells a range of beverages, alcoholic beverages, and a small quantity of tea and fruit juice. The alcoholic beverages it sells include Chinese liquor, French cognac, Scottish whiskey, fine wine, Champagne, and other miscellaneous beverage alcohol.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.